{"id":22621,"date":"2025-09-23T10:45:52","date_gmt":"2025-09-23T10:45:52","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg"},"modified":"2026-03-25T11:10:50","modified_gmt":"2026-03-25T11:10:50","slug":"fluvastatina-qualigen-efg","status":"publish","type":"portfolio-products","link":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg","title":{"rendered":"Fluvastatina Qualigen EFG"},"content":{"rendered":"

Dislipidemia<\/p>\n

Tratamiento de adultos con hipercolesterolemia primaria o dislipemia mixta, como tratamiento adjunto a la dieta, cuando la respuesta obtenida con la dieta y otros tratamientos no farmacol\u00f3gicos (p.ej. ejercicio f\u00edsico, reducci\u00f3n del peso) no ha sido suficiente.<\/p>\n

Prevenci\u00f3n secundaria en la enfermedad cardiaca coronaria.<\/p>\n

Prevenci\u00f3n secundaria de eventos cardiacos adversos mayores en adultos con enfermedad cardiaca coronaria tras una intervenci\u00f3n coronaria percut\u00e1nea.<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","product-category":[172],"therapeutic-area":[184],"active-substance":[225],"class_list":["post-22621","portfolio-products","type-portfolio-products","status-publish","hentry","product-category-farmacia","therapeutic-area-hipercolesterolemia","active-substance-fluvastatina"],"yoast_head":"\nFluvastatina Qualigen EFG - Neuraxpharm Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fluvastatina Qualigen EFG\" \/>\n<meta property=\"og:description\" content=\"Dislipidemia Tratamiento de adultos con hipercolesterolemia primaria o dislipemia mixta, como tratamiento adjunto a la dieta, cuando la respuesta obtenida con la dieta y otros tratamientos no farmacol\u00f3gicos (p.ej. ejercicio f\u00edsico, reducci\u00f3n del peso) no ha sido suficiente. Prevenci\u00f3n secundaria en la enfermedad cardiaca coronaria. Prevenci\u00f3n secundaria de eventos cardiacos adversos mayores en adultos con […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Espa\u00f1a\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-25T11:10:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/04\/neuraxpharm-your-cns-specialist.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1779\" \/>\n\t<meta property=\"og:image:height\" content=\"995\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg\",\"name\":\"Fluvastatina Qualigen EFG - Neuraxpharm Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\"},\"datePublished\":\"2025-09-23T10:45:52+00:00\",\"dateModified\":\"2026-03-25T11:10:50+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/\",\"name\":\"Neuraxpharm Espa\u00f1a\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Fluvastatina Qualigen EFG - Neuraxpharm Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg","og_locale":"es_ES","og_type":"article","og_title":"Fluvastatina Qualigen EFG","og_description":"Dislipidemia Tratamiento de adultos con hipercolesterolemia primaria o dislipemia mixta, como tratamiento adjunto a la dieta, cuando la respuesta obtenida con la dieta y otros tratamientos no farmacol\u00f3gicos (p.ej. ejercicio f\u00edsico, reducci\u00f3n del peso) no ha sido suficiente. Prevenci\u00f3n secundaria en la enfermedad cardiaca coronaria. Prevenci\u00f3n secundaria de eventos cardiacos adversos mayores en adultos con […]","og_url":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg","og_site_name":"Neuraxpharm Espa\u00f1a","article_modified_time":"2026-03-25T11:10:50+00:00","og_image":[{"width":1779,"height":995,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/04\/neuraxpharm-your-cns-specialist.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg","url":"https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg","name":"Fluvastatina Qualigen EFG - Neuraxpharm Espa\u00f1a","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/es\/#website"},"datePublished":"2025-09-23T10:45:52+00:00","dateModified":"2026-03-25T11:10:50+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/es\/portfolio\/fluvastatina-qualigen-efg"]}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/es\/#website","url":"https:\/\/www.neuraxpharm.com\/es\/","name":"Neuraxpharm Espa\u00f1a","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products\/22621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/types\/portfolio-products"}],"version-history":[{"count":9,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products\/22621\/revisions"}],"predecessor-version":[{"id":33316,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/portfolio-products\/22621\/revisions\/33316"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media?parent=22621"}],"wp:term":[{"taxonomy":"product-category","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/product-category?post=22621"},{"taxonomy":"therapeutic-area","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/therapeutic-area?post=22621"},{"taxonomy":"active-substance","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/active-substance?post=22621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}